US Nasdaq stock alert

USA

End of Day Alert: Amgen hits 52-week high seventh time in one month 21 September 2018 18:14 EDT

NEWS BITES - NORTH AMERICA

Amgen, NASDAQ's largest medical/biomedical company by market capitalisation, hit a 52-week high of $US206.62 today for the seventh time in the past one month and last traded at $US205.10. Trading volume was 2.2 times average at the end of the day. Compared with the NASDAQ-100 Index which fell 38.0 points (or 0.5%) in the day, this represented a relative price increase of 0.5%.

Technical indicators complementing today's significant uptrend:

+ The positive 2.27 MACD (Moving Average Convergence Divergence) indicator suggests a bullish signal.

+ In the last three months the stock has hit a new 52-week high nine times, pointing to a significant uptrend.

+ The price lifted 2.3% in the last week and 3.9% in the last month.

Fundamental measures by comparison with the sector average [in brackets] indicate:

Undervaluation:

+ Dividend yield of 2.5% [0.9%]

Other Bullish Signals include:

+ The company is cash rich with Cash to Market Capitalisation at 27.9%.

+ Tobin's Q Ratio is 1.7. Compared with the rest of the market the stock is undervalued.

+ Net profit margin has averaged 24.8% in the last 3 years. This is considered superior and suggests a high margin of safety.

Note

The stock has outperformed 71% of the NASDAQ market over the past 6 months.

Bearish Signals:

As per the Du Pont analysis, Return on Equity is less than stellar at 7.8%. Also, this has deteriorated from 25.8% last year.

Overbought/Bearish:

The 0.7% discount to 12-month high of $US206.62 against the 27.4% premium to 12-month low of $US160.96 suggests the climb might be peaking.

Fundamental measures by comparison with the sector average [in brackets] indicate:

Overvaluation:

Return on Equity 7.8% [10.1%]

Return on Assets 2.5% [3.7%]

RECENT ALERTS

End of Day Alert: Amgen hits 52-week high sixth time in one month

20 September 2018 17:53 EDT

Amgen, NASDAQ's largest medical/biomedical company by market capitalisation, hit a 52-week high of $US205.25 today for the sixth time in the past one month and last traded at $US205.10. This brought its four-day rise to $US4.52 or 2.3%. Trading volume was 66% of average at the end of the day. Compared with the NASDAQ-100 Index which rose 78.7 points (or 1.1%) in the day, this represented a relative price change of -0.1%.

Afternoon Alert: Amgen hits 52-week high sixth time in one month

20 September 2018 12:33 EDT

Amgen Inc. (NASDAQ:AMGN) hit a 52-week high of $US205.13 today for the sixth time in the past one month and last traded at $US204.30. This brought its four-day rise to $US3.72 or 1.9%. Trading volume was 1.2 times average so far today.

Amgen Inc. (O:AMGN)

ISIN: US0311621009

PermID: 4295905537

CIK: 318154

CUSIP: 031162100

Source: www.BuySellSignals.com